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Aptamers are oligonucleotide ligands that 
form unique secondary and tertiary struc-
tures, such as stem loops, kinks, bulges, 
and pseudoknots. Each aptamer exhibits a 
unique interface, through its structure, that 
specifically recognizes the target molecule. 
In fact, the target recognition of aptamers is 
highly specific, and it has been reported that 
an aptamer is able to discriminate between 
closely related isoforms or different con-
formational states of the same molecule 
(Conrad and Ellington, 1996; Proske et al., 
2002).
  Aptamers are often compared with 
antibodies due to their high specificity 
and affinity to the targets; however, they 
have some advantages over antibodies. 
For instance, antibodies require animals 
to be generated. Aptamers are generated 
by in vitro chemical synthesis, which ena-
bles chemical modification to control 
their stability or to add fluorescent dye on 
demand. Moreover, antibodies basically 
function in extracellular regions, whereas 
aptamers are easily introduced into the 
intra-cellular compartment by transfec-
tion. Loss-of-function technologies such as 
gene knockout, antisense oligonucleotide, 
and RNA interference (RNAi) are actively 
utilized for gene targeting. These aim to 
address the function of a target product 
through gene inactivation at the genomic 
or transcriptional level. Proteins often have 
multiple functions and work as part of 
multiprotein complex. It is often   difficult 
especially RNAs, are readily broken down 
by nucleases in organisms, aptamers have 
to evade from attack of nucleases for ther-
apeutic use. 2′-Fluoropyrimidine modifi-
cation, 2′-O-methyl nucleotides, or 3′ end 
cap modification has been developed to 
achieve resistance to nucleases (Keefe and 
Cload, 2008). Thus, aptamers are potent 
therapeutic reagents. In addition, aptamers 
can be an excellent tool for drug discovery, 
and a competitive   screening method has 
been  developed (Green et al., 2001). A large 
pool of chemical compounds is screened 
against an aptamer/target complex. Only 
a chemical compound capable of binding 
the target molecule with equivalent or 
higher affinity than the aptamer/target 
can displace the aptamer from the target 
molecule. This aptamer approach enables 
high-throughput screening of potent drug 
candidates. Of note, the aptamer approach 
is applicable even if the natural ligand/
substrate is unknown. Aptamers can also 
be a useful tool for basic research by spe-
cifically targeting and disrupting the func-
tions of viral or host protein involved in 
viral replications. For example, Binning 
et al. (2012) described an aptamer tar-
geting Tax of human T-cell leukemia 
virus and those targeting NC of human 
immunodeficiency virus. Thus, aptamers 
can provide invaluable insight into viral 
replication.
  Over two decades have passed since the 
initial description of a screening method of 
aptamers, so called systematic evolution of 
ligands by exponential enrichment (SELEX; 
Ellington and Szostak, 1990; Tuerk and 
Gold, 1990) and applications using aptam-
ers have become more sophisticated and 
are increasing. Now is a good time for all 
researchers in the virus research field to 
consider the use of aptamers.
to validate the functional relevance of the 
proteins by deletion at the genomic or 
transcriptional level. Aptamers are appli-
cable to these proteins since aptamers can 
directly bind target proteins. As protein-
based target validation reagents other than 
antibodies, peptides derived from phage 
display libraries are available. These pep-
tides, however, require in vivo production, 
and in part, exhibit poor specificity to the 
target molecules, which remains to be 
overcome for general application. Thus, 
aptamers have some advantages over other 
technologies currently used, and have 
potential for a broad range of application, 
such as diagnostic, therapeutic, and basic 
research (Figure 1).
  Binning et al. (2012) summarized the 
recent developments and future prospects 
of aptamers in the virus research field. 
Early and reliable detection of pathogens 
is important for the successful treatment 
and prevention of virus epidemics. As a 
diagnostic tool, aptamers have ideal prop-
erties, such as (1) highly specific and tight 
affinity to target molecule, (2) facilitation 
of modification, and (3) stability. Due 
to these advantages, aptamers are being 
actively investigated as a diagnostic tool. 
In addition, aptamers can be coupled to 
existing biosensors, achieving very high 
sensitivity (Zhou et al., 2010). Aptamers 
can also be exploited as therapeutic rea-
gents. As mentioned above, aptamers can 
be located in both extra- and intra-cellular 
regions, where they are capable of target-
ing any viral components. In fact, aptam-
ers have been reported to work in various 
viral replication steps, such as entry, tran-
scription, translation, and genome pack-
aging (Binning et al., 2012). Furthermore, 
aptamers exhibit little or no immunogenic-
ity and toxicity. Since   oligonucleotides, 
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Figure 1 | Possible applications of aptamers in virus research. (A) Aptamers as 
diagnostic tools. Aptamers exhibit highly specific recognition with very tight affinity 
(Kd < 1 nM) to the target molecules. Aptamer-based detection assays are expected to 
reach lower detection limits than conventional antibody-based detection assays such 
as ELISA. (B) Aptamers as therapeutics. Due to specific and tight affinity to the target 
molecules, and low or no immunogenicity and toxicity, aptamers are expected to be 
effective therapeutic reagents. Moreover, aptamers are capable of existing in 
extra- and intra-cellular regions, indicating that any viral components can be targeted 
by aptamers. (C) Aptamers as a basic research tool. Antibodies or peptides derived 
from phage display libraries are generally used for protein-based target validation. 
Aptamers have some advantages over these methods because of their short 
development time, in vitro synthesis, and high specificity.
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